-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On November 1st, also the first day of November, many companies had news about changes in senior management positions, and two of them were highly concerned
First of all, Janssen Pharmaceuticals announced a major change in the management team on November 1, including the Medical Affairs Department, the Immunization and Pulmonary Hypertension Business Department, and the Commercial Department
The person in charge of the Medical Affairs Department has been officially determined.
Before joining Yangsen China, Dr.
Dr.
After that, Dr.
Next, Dr.
In addition, Yang Sen also announced the appointment of He Xuzheng as Vice President and Head of Immunization and Pulmonary Hypertension Business Unit from December 1st.
Head of AstraZeneca and county operations resigns
Head of AstraZeneca and county operations resignsOn November 1, Lai Minglong, general manager of AstraZeneca China, announced a personnel change in Jixian business to employees.
Du Haochen’s departure has attracted the attention of many friends.
Note: The original text has been deleted